ISP-001

Sleeping Beauty transposon-engineered B cells · Immusoft of CA, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISP-001, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I [Phase 1]